SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-17-000228
Filing Date
2017-06-15
Accepted
2017-06-15 10:21:33
Documents
63
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt043017form10q.htm 10-Q 738269
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 22065
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 21398
4 EXHIBIT 32 ex32.htm EX-32 4219
  Complete submission text file 0001607062-17-000228.txt   3407520

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20170430.xml EX-101.INS 417844
6 XBRL SCHEMA FILE gnbt-20170430.xsd EX-101.SCH 51621
7 XBRL CALCULATION FILE gnbt-20170430_cal.xml EX-101.CAL 35975
8 XBRL DEFINITION FILE gnbt-20170430_def.xml EX-101.DEF 187298
9 XBRL LABEL FILE gnbt-20170430_lab.xml EX-101.LAB 267513
10 XBRL PRESENTATION FILE gnbt-20170430_pre.xml EX-101.PRE 246808
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0320
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 17912646
SIC: 2834 Pharmaceutical Preparations